Sionna Therapeutics, Inc. (SION) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Orbimed Advisors LLC entity

Director

$9.90M (1)

$55.67M (20) scheduled

−$45.77M

2,469,959

5.46%

$18.43M

—

Peter A. Thompson

Director

$9.90M (1)

$55.67M (20) scheduled

−$45.77M

2,469,959

5.46%

$18.43M

—

Ra Capital Management, L.p. entity

Director

$20.25M (2)

$43.30M (46)

−$23.05M

318,066

0.7035%

$2.37M

—

Bruce Booth

Director

$1.08M (1)

$22.09M (50) scheduled

−$21.01M

686,567

1.52%

$5.12M

—

Tpg Gp A, LLC entity

10% owner

$21.20M (2)

$10.00M (1)

+$11.20M

6,494,962

14.37%

$48.45M

+849.0%

Michael Cloonan

President & CEO

—

$6.33M (12) scheduled

−$6.33M

765,393

1.69%

$5.71M

+39.8%

Elena Ridloff

CFO and CBO

—

$1.97M (7) scheduled

−$1.97M

133,069

0.2943%

$992.69K

+7.7%

Jennifer Fitzpatrick

CLO and Head of Program Mgmt.

—

$1.45M (4) scheduled

−$1.45M

56,265

0.1244%

$419.74K

—

Atlas Venture Fund XI, L.P. entity

10% owner

$1.08M (1)

—

+$1.08M

3,694,020

8.17%

$27.56M

—

Charlotte McKee

CMO and Head of R&D

—

128,415

0.2840%

$957.98K

+351.9%

Sionna Therapeutics, Inc.

What the insiders did Net buying

By person